FILINGS
ADXN 0001574232 | |||
---|---|---|---|
Filing Date | Form Type | Description | Document |
2024-11-22 | 6-K | FORM 6-K | View Document |
2024-11-12 | 6-K | FORM 6-K | View Document |
2024-09-30 | 6-K | FORM 6-K | View Document |
2024-09-19 | 6-K | FORM 6-K | View Document |
2024-08-27 | 6-K | FORM 6-K | View Document |
2024-08-14 | SC 13D/A | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#7E) | View Document |
2024-08-05 | SC 13D/A | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#6) | View Document |
2024-07-22 | 6-K | FORM 6-K | View Document |
2024-07-15 | 6-K | FORM 6-K | View Document |
2024-07-01 | 6-K | FORM 6-K | View Document |
2024-06-06 | 6-K | FORM 6-K | View Document |
2024-06-05 | 6-K | FORM 6-K | View Document |
2024-04-29 | 6-K | FORM 6-K | View Document |
2024-04-24 | 424B3 | 424B3 | View Document |
2024-04-22 | EFFECT | View Document | |
2024-04-18 | POS AM | POS AM | View Document |
2024-04-18 | 20-F | FORM 20-F | View Document |
2024-04-18 | 6-K | FORM 6-K | View Document |
2024-04-03 | 6-K | FORM 6-K | View Document |
2024-01-30 | 424B5 | 424B5 | View Document |
2024-01-30 | 6-K | FORM 6-K | View Document |
2023-12-21 | 6-K/A | FORM 6-K/A | View Document |
2023-12-20 | 6-K | FORM 6-K | View Document |
2023-12-14 | 6-K | FORM 6-K | View Document |
2023-12-08 | SC 13D/A | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#5) | View Document |
2023-11-30 | 424B3 | 424B3 | View Document |
2023-11-29 | EFFECT | View Document | |
2023-11-29 | SC 13D/A | SC 13D/A | View Document |
2023-11-29 | POS AM | POS AM | View Document |
2023-11-29 | 6-K | FORM 6-K | View Document |
2023-11-28 | 6-K | FORM 6-K | View Document |
2023-11-14 | 6-K | FORM 6-K | View Document |
2023-11-08 | 6-K | FORM 6-K | View Document |
2023-10-23 | 424B3 | 424B3 | View Document |
2023-10-20 | 6-K | FORM 6-K | View Document |
2023-10-06 | F-6 POS | View Document | |
2023-10-06 | 6-K | FORM 6-K | View Document |
2023-09-20 | 6-K | FORM 6-K | View Document |
2023-09-05 | 6-K | FORM 6-K | View Document |
2023-09-05 | 6-K | FORM 6-K | View Document |
2023-08-11 | 424B3 | 424B3 | View Document |
2023-08-10 | EFFECT | View Document | |
2023-08-10 | POS AM | POS AM | View Document |
2023-08-10 | 6-K | FORM 6-K | View Document |
2023-08-03 | 6-K | FORM 6-K | View Document |
2023-07-24 | 6-K | FORM 6-K | View Document |
2023-06-15 | 6-K | FORM 6-K | View Document |
2023-06-08 | S-8 | FORM S-8 | View Document |
2023-06-02 | EFFECT | View Document | |
2023-06-02 | 424B3 | 424B3 | View Document |
2023-06-01 | CORRESP | View Document | |
2023-06-01 | F-1/A | FORM F-1/A | View Document |
2023-06-01 | 6-K | FORM 6-K | View Document |
2023-05-18 | 6-K | FORM 6-K | View Document |
2023-05-12 | CORRESP | View Document | |
2023-05-11 | CORRESP | View Document | |
2023-05-11 | F-1/A | F-1/A | View Document |
2023-05-11 | 6-K | FORM 6-K | View Document |
2023-05-10 | 6-K | FORM 6-K | View Document |
2023-05-09 | UPLOAD | View Document | |
2023-05-05 | 6-K | FORM 6-K | View Document |
2023-05-03 | F-1 | F-1 | View Document |
2023-04-13 | D | View Document | |
2023-04-10 | SC 13D/A | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#4) | View Document |
2023-04-05 | SC 13D/A | SC 13D/A | View Document |
2023-04-04 | 424B5 | 424B5 | View Document |
2023-04-04 | 6-K | FORM 6-K | View Document |
2023-04-04 | 6-K | FORM 6-K | View Document |
2023-04-03 | 6-K | FORM 6-K | View Document |
2023-03-31 | SC 13D/A | SC 13D/A | View Document |
2023-03-30 | 6-K | FORM 6-K | View Document |
2023-03-30 | 20-F | FORM 20-F | View Document |
2023-02-16 | SC 13G/A | View Document | |
2023-02-14 | SC 13G/A | View Document | |
2023-02-14 | SC 13G/A | View Document | |
2023-02-09 | 6-K | FORM 6-K | View Document |
2023-02-08 | SC 13G/A | View Document | |
2023-02-06 | SC 13G/A | SC 13G/A | View Document |
2023-02-06 | 6-K | FORM 6-K | View Document |
2023-01-19 | 6-K | FORM 6-K | View Document |
2022-12-08 | 6-K | FORM 6-K | View Document |
2022-11-28 | SC 13D/A | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A3 | View Document |
2022-11-23 | SC 13D/A | SC 13D/A | View Document |
2022-11-22 | 424B3 | 424B3 | View Document |
2022-11-16 | 424B3 | 424B3 | View Document |
2022-11-14 | 6-K | FORM 6-K | View Document |
2022-11-09 | SC 13D/A | SC 13D/A | View Document |
2022-11-03 | 6-K | FORM 6-K | View Document |
2022-11-01 | 6-K | FORM 6-K | View Document |
2022-09-14 | 6-K/A | FORM 6-K/A | View Document |
2022-08-30 | 424B3 | 424B3 | View Document |
2022-08-29 | EFFECT | View Document | |
2022-08-29 | EFFECT | View Document | |
2022-08-25 | CORRESP | View Document | |
2022-08-25 | UPLOAD | View Document | |
2022-08-24 | POS AM | POS AM | View Document |
2022-08-23 | SC 13D/A | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A2 | View Document |
2022-08-19 | F-1 | F-1 | View Document |
2022-08-18 | 6-K | FORM 6-K | View Document |
2022-08-15 | 6-K | FORM 6-K | View Document |
Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.